Global Oral Cholera Vaccine Competitive Landscape Professional Research Report 2025
Research Summary
The oral cholera vaccine is a preventative measure against cholera, a potentially deadly diarrheal disease caused by the bacterium Vibrio cholerae. Unlike traditional vaccines that are administered via injection, the oral cholera vaccine is ingested orally. It contains weakened or killed strains of Vibrio cholerae, or recombinant strains of the bacteria, which stimulate the immune system to produce antibodies against cholera. Once ingested, the vaccine triggers an immune response in the gut, providing protection against future exposure to cholera bacteria. Oral cholera vaccines are typically administered in two doses, spaced a few weeks apart, and provide immunity for several years. They are used primarily in areas where cholera is endemic or during outbreaks to prevent the spread of the disease, particularly in communities with poor sanitation and hygiene conditions.
According to DIResearch's in-depth investigation and research, the global Oral Cholera Vaccine market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Oral Cholera Vaccine include PaxVax, Sanofi, Valneva, EuBiologics, United Biotech, Vabiotech etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Oral Cholera Vaccine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Oral Cholera Vaccine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Oral Cholera Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Oral Cholera Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Oral Cholera Vaccine Include:
PaxVax
Sanofi
Valneva
EuBiologics
United Biotech
Vabiotech
Oral Cholera Vaccine Product Segment Include:
Euvichol-Plus
DUKORAL
Shanchol
Others
Oral Cholera Vaccine Product Application Include:
Preventive Campaigns
Outbreak Response
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Oral Cholera Vaccine Industry PESTEL Analysis
Chapter 3: Global Oral Cholera Vaccine Industry Porter’s Five Forces Analysis
Chapter 4: Global Oral Cholera Vaccine Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Oral Cholera Vaccine Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Oral Cholera Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Oral Cholera Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Oral Cholera Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Oral Cholera Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Oral Cholera Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Oral Cholera Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Oral Cholera Vaccine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Oral Cholera Vaccine Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Oral Cholera Vaccine Product by Type
- 1.2.1 Euvichol-Plus
- 1.2.2 DUKORAL
- 1.2.3 Shanchol
- 1.2.4 Others
- 1.3 Oral Cholera Vaccine Product by Application
- 1.3.1 Preventive Campaigns
- 1.3.2 Outbreak Response
- 1.4 Global Oral Cholera Vaccine Market Revenue and Sales Analysis
- 1.4.1 Global Oral Cholera Vaccine Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Oral Cholera Vaccine Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Oral Cholera Vaccine Market Sales Price Trend Analysis (2020-2032)
- 1.5 Oral Cholera Vaccine Industry Trends and Innovation
- 1.5.1 Oral Cholera Vaccine Industry Trends and Innovation
- 1.5.2 Oral Cholera Vaccine Market Drivers and Challenges
- 2 Oral Cholera Vaccine Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Oral Cholera Vaccine Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Oral Cholera Vaccine Market Analysis by Regions
- 4.1 Oral Cholera Vaccine Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Oral Cholera Vaccine Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Oral Cholera Vaccine Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Oral Cholera Vaccine Revenue and Market Share Forecast by Region (2026-2032)
- 4.3 Global Oral Cholera Vaccine Sales and Forecast Analysis (2020-2032)
- 4.3.1 Global Oral Cholera Vaccine Sales and Market Share by Region (2020-2025)
- 4.3.2 Global Oral Cholera Vaccine Sales Forecast by Region (2026-2032)
- 4.4 Global Oral Cholera Vaccine Sales Price Trend Analysis (2020-2032)
- 5 Global Oral Cholera Vaccine Market Size by Type and Application
- 5.1 Global Oral Cholera Vaccine Market Size by Type
- 5.1.1 Global Oral Cholera Vaccine Revenue and Forecast Analysis by Type (2020-2032)
- 5.1.2 Global Oral Cholera Vaccine Sales and Forecast Analysis by Type (2020-2032)
- 5.2 Global Oral Cholera Vaccine Market Size by Application
- 5.2.1 Global Oral Cholera Vaccine Revenue and Forecast Analysis by Application (2020-2032)
- 5.2.2 Global Oral Cholera Vaccine Sales and Forecast Analysis by Application (2020-2032)
- 6 North America
- 6.1 North America Oral Cholera Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Oral Cholera Vaccine Market Size by Type
- 6.3.1 North America Oral Cholera Vaccine Sales by Type (2020-2032)
- 6.3.2 North America Oral Cholera Vaccine Revenue by Type (2020-2032)
- 6.4 North America Oral Cholera Vaccine Market Size by Application
- 6.4.1 North America Oral Cholera Vaccine Sales by Application (2020-2032)
- 6.4.2 North America Oral Cholera Vaccine Revenue by Application (2020-2032)
- 6.5 North America Oral Cholera Vaccine Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Oral Cholera Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Oral Cholera Vaccine Market Size by Type
- 7.3.1 Europe Oral Cholera Vaccine Sales by Type (2020-2032)
- 7.3.2 Europe Oral Cholera Vaccine Revenue by Type (2020-2032)
- 7.4 Europe Oral Cholera Vaccine Market Size by Application
- 7.4.1 Europe Oral Cholera Vaccine Sales by Application (2020-2032)
- 7.4.2 Europe Oral Cholera Vaccine Revenue by Application (2020-2032)
- 7.5 Europe Oral Cholera Vaccine Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Oral Cholera Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Oral Cholera Vaccine Market Size by Type
- 8.3.1 China Oral Cholera Vaccine Sales by Type (2020-2032)
- 8.3.2 China Oral Cholera Vaccine Revenue by Type (2020-2032)
- 8.4 China Oral Cholera Vaccine Market Size by Application
- 8.4.1 China Oral Cholera Vaccine Sales by Application (2020-2032)
- 8.4.2 China Oral Cholera Vaccine Revenue by Application (2020-2032)
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Oral Cholera Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Oral Cholera Vaccine Market Size by Type
- 9.3.1 APAC (excl. China) Oral Cholera Vaccine Sales by Type (2020-2032)
- 9.3.2 APAC (excl. China) Oral Cholera Vaccine Revenue by Type (2020-2032)
- 9.4 APAC (excl. China) Oral Cholera Vaccine Market Size by Application
- 9.4.1 APAC (excl. China) Oral Cholera Vaccine Sales by Application (2020-2032)
- 9.4.2 APAC (excl. China) Oral Cholera Vaccine Revenue by Application (2020-2032)
- 9.5 APAC (excl. China) Oral Cholera Vaccine Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Oral Cholera Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Oral Cholera Vaccine Market Size by Type
- 10.3.1 Latin America Oral Cholera Vaccine Sales by Type (2020-2032)
- 10.3.2 Latin America Oral Cholera Vaccine Revenue by Type (2020-2032)
- 10.4 Latin America Oral Cholera Vaccine Market Size by Application
- 10.4.1 Latin America Oral Cholera Vaccine Sales by Application (2020-2032)
- 10.4.2 Latin America Oral Cholera Vaccine Revenue by Application (2020-2032)
- 10.5 Latin America Oral Cholera Vaccine Market Size by Country
- 10.6 Latin America Oral Cholera Vaccine Market Size by Country
- 10.6.1 Mexico
- 10.6.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Oral Cholera Vaccine Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Oral Cholera Vaccine Market Size by Type
- 11.3.1 Middle East & Africa Oral Cholera Vaccine Sales by Type (2020-2032)
- 11.3.2 Middle East & Africa Oral Cholera Vaccine Revenue by Type (2020-2032)
- 11.4 Middle East & Africa Oral Cholera Vaccine Market Size by Application
- 11.4.1 Middle East & Africa Oral Cholera Vaccine Sales by Application (2020-2032)
- 11.4.2 Middle East & Africa Oral Cholera Vaccine Revenue by Application (2020-2032)
- 11.5 Middle East Oral Cholera Vaccine Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Oral Cholera Vaccine Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 12.1.1 Global Oral Cholera Vaccine Market Sales by Key Manufacturers (2021-2025)
- 12.1.2 Global Oral Cholera Vaccine Market Revenue by Key Manufacturers (2021-2025)
- 12.1.3 Global Oral Cholera Vaccine Average Sales Price by Manufacturers (2021-2025)
- 12.2 Oral Cholera Vaccine Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Oral Cholera Vaccine Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 PaxVax
- 13.1.1 PaxVax Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 PaxVax Oral Cholera Vaccine Product Portfolio
- 13.1.3 PaxVax Oral Cholera Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.2 Sanofi
- 13.2.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Sanofi Oral Cholera Vaccine Product Portfolio
- 13.2.3 Sanofi Oral Cholera Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.3 Valneva
- 13.3.1 Valneva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Valneva Oral Cholera Vaccine Product Portfolio
- 13.3.3 Valneva Oral Cholera Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.4 EuBiologics
- 13.4.1 EuBiologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 EuBiologics Oral Cholera Vaccine Product Portfolio
- 13.4.3 EuBiologics Oral Cholera Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.5 United Biotech
- 13.5.1 United Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 United Biotech Oral Cholera Vaccine Product Portfolio
- 13.5.3 United Biotech Oral Cholera Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.6 Vabiotech
- 13.6.1 Vabiotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Vabiotech Oral Cholera Vaccine Product Portfolio
- 13.6.3 Vabiotech Oral Cholera Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Oral Cholera Vaccine Industry Chain Analysis
- 14.2 Oral Cholera Vaccine Industry Raw Material and Suppliers Analysis
- 14.2.1 Oral Cholera Vaccine Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Oral Cholera Vaccine Typical Downstream Customers
- 14.4 Oral Cholera Vaccine Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook